vs
POTLATCHDELTIC CORP（PCH）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
POTLATCHDELTIC CORP的季度营收约是REPLIGEN CORP的1.6倍（$314.2M vs $197.9M），POTLATCHDELTIC CORP净利率更高（8.2% vs 6.7%，领先1.5%），POTLATCHDELTIC CORP同比增速更快（23.1% vs 13.6%），POTLATCHDELTIC CORP自由现金流更多（$50.1M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 11.1%）
PotlatchDeltic是一家总部位于美国华盛顿州斯波坎的多元化林产品企业，业务覆盖林木培育、木材加工及相关林制品的生产与供应，在林业资源管理和产品研发领域拥有成熟的运营体系，为建筑、家居等多个下游行业提供优质原材料与产品解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PCH vs RGEN — 直观对比
营收规模更大
PCH
是对方的1.6倍
$197.9M
营收增速更快
PCH
高出9.5%
13.6%
净利率更高
PCH
高出1.5%
6.7%
自由现金流更多
PCH
多$32.6M
$17.6M
两年增速更快
RGEN
近两年复合增速
11.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $314.2M | $197.9M |
| 净利润 | $25.9M | $13.3M |
| 毛利率 | 18.2% | 52.5% |
| 营业利润率 | 11.2% | 9.0% |
| 净利率 | 8.2% | 6.7% |
| 营收同比 | 23.1% | 13.6% |
| 净利润同比 | 682.5% | 143.9% |
| 每股收益（稀释后） | $0.33 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PCHRGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | $314.2M | $188.8M | ||
| Q2 25 | $275.0M | $182.4M | ||
| Q1 25 | $268.3M | $169.2M | ||
| Q4 24 | $258.1M | $174.1M | ||
| Q3 24 | $255.1M | $154.9M | ||
| Q2 24 | $320.7M | $154.1M | ||
| Q1 24 | $228.1M | $151.3M |
净利润PCHRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $25.9M | $14.9M | ||
| Q2 25 | $7.4M | $14.9M | ||
| Q1 25 | $25.8M | $5.8M | ||
| Q4 24 | $5.2M | $-30.3M | ||
| Q3 24 | $3.3M | $-654.0K | ||
| Q2 24 | $13.7M | $3.3M | ||
| Q1 24 | $-305.0K | $2.1M |
毛利率PCHRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | 18.2% | 53.2% | ||
| Q2 25 | 13.0% | 50.0% | ||
| Q1 25 | 17.8% | 53.6% | ||
| Q4 24 | 13.4% | 26.1% | ||
| Q3 24 | 10.8% | 50.0% | ||
| Q2 24 | 11.9% | 49.8% | ||
| Q1 24 | 7.0% | 49.5% |
营业利润率PCHRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | 11.2% | 8.9% | ||
| Q2 25 | 5.0% | 7.6% | ||
| Q1 25 | 10.3% | 3.9% | ||
| Q4 24 | 5.2% | -17.7% | ||
| Q3 24 | 2.8% | -5.1% | ||
| Q2 24 | 5.4% | 1.0% | ||
| Q1 24 | -2.1% | 1.3% |
净利率PCHRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 8.2% | 7.9% | ||
| Q2 25 | 2.7% | 8.2% | ||
| Q1 25 | 9.6% | 3.4% | ||
| Q4 24 | 2.0% | -17.4% | ||
| Q3 24 | 1.3% | -0.4% | ||
| Q2 24 | 4.3% | 2.2% | ||
| Q1 24 | -0.1% | 1.4% |
每股收益（稀释后）PCHRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.33 | $0.26 | ||
| Q2 25 | $0.09 | $0.26 | ||
| Q1 25 | $0.33 | $0.10 | ||
| Q4 24 | $0.07 | $-0.55 | ||
| Q3 24 | $0.04 | $-0.01 | ||
| Q2 24 | $0.17 | $0.06 | ||
| Q1 24 | $0.00 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.8M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $3.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PCHRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | $88.8M | $748.7M | ||
| Q2 25 | $95.3M | $708.9M | ||
| Q1 25 | $147.5M | $697.2M | ||
| Q4 24 | $151.6M | $757.4M | ||
| Q3 24 | $161.1M | $784.0M | ||
| Q2 24 | $199.7M | $809.1M | ||
| Q1 24 | $180.2M | $780.6M |
总债务PCHRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0B | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PCHRGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | $1.9B | $2.1B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $2.0B | $2.0B | ||
| Q4 24 | $2.0B | $2.0B | ||
| Q3 24 | $2.1B | $2.0B | ||
| Q2 24 | $2.1B | $2.0B | ||
| Q1 24 | $2.2B | $2.0B |
总资产PCHRGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | $3.2B | $2.9B | ||
| Q2 25 | $3.2B | $2.9B | ||
| Q1 25 | $3.3B | $2.9B | ||
| Q4 24 | $3.3B | $2.8B | ||
| Q3 24 | $3.3B | $2.8B | ||
| Q2 24 | $3.4B | $2.9B | ||
| Q1 24 | $3.4B | $2.8B |
负债/权益比PCHRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.51× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $65.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $50.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 15.9% | 8.9% |
| 资本支出强度资本支出/营收 | 4.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.54× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $132.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PCHRGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $65.7M | $48.1M | ||
| Q2 25 | $41.0M | $28.6M | ||
| Q1 25 | $49.1M | $15.0M | ||
| Q4 24 | $45.4M | $39.2M | ||
| Q3 24 | $26.5M | $49.3M | ||
| Q2 24 | $100.6M | $42.2M | ||
| Q1 24 | $16.0M | $44.7M |
自由现金流PCHRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $50.1M | $43.4M | ||
| Q2 25 | $30.6M | $21.5M | ||
| Q1 25 | $26.3M | $11.4M | ||
| Q4 24 | $25.4M | $33.6M | ||
| Q3 24 | $-8.2M | $42.3M | ||
| Q2 24 | $72.4M | $37.4M | ||
| Q1 24 | $2.0M | $36.4M |
自由现金流率PCHRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | 15.9% | 23.0% | ||
| Q2 25 | 11.1% | 11.8% | ||
| Q1 25 | 9.8% | 6.8% | ||
| Q4 24 | 9.9% | 19.3% | ||
| Q3 24 | -3.2% | 27.3% | ||
| Q2 24 | 22.6% | 24.3% | ||
| Q1 24 | 0.9% | 24.0% |
资本支出强度PCHRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | 4.9% | 2.5% | ||
| Q2 25 | 3.8% | 3.9% | ||
| Q1 25 | 8.5% | 2.1% | ||
| Q4 24 | 7.7% | 3.2% | ||
| Q3 24 | 13.6% | 4.5% | ||
| Q2 24 | 8.8% | 3.1% | ||
| Q1 24 | 6.1% | 5.5% |
现金转化率PCHRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.54× | 3.23× | ||
| Q2 25 | 5.58× | 1.92× | ||
| Q1 25 | 1.90× | 2.57× | ||
| Q4 24 | 8.74× | — | ||
| Q3 24 | 7.99× | — | ||
| Q2 24 | 7.35× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
RGEN
暂无分部数据
